On the afternoon of January 30, 2015, all the employees of Yidu Zhengkang attended the "Hand in hand, thank you for having you - 2014 Annual Conference" sponsored by the holding company. Summarize 2014 and look forward to 2015

On May 7, 2021, the third new anticancer drug PARP inhibitor tislelizumab independently developed by BeiGene (generic name: Pamiparib) was officially approved by the National Medical Products Administration (NMPA) with conditions. As a registered service provider of BeiGene, Yeedozencom congratulates tislelizumab for bringing new treatment options to both platinum sensitive and platinum resistant patients with relapsed ovarian cancer.

On April 19, the "2021 Scientific Seminar on Drug Innovation & Drug Supervision - and the First Academic Annual Conference of China Food and Drug Supervision and Administration Journal" sponsored by China Health Media Group and China Association of Drug Supervision and Administration was held as scheduled at the Kepinsky Hotel on the banks of Jinji Lake. The Conference shall focus on "new stages and new patterns, new methods and new technologies", thoroughly study and implement the spirit of the two sessions, discuss the scientific development of drug innovation and drug supervision, actively serve and empower pharmaceutical enterprises to develop, innovate and develop at high quality, and compose a new chapter of drug supervision at the new development stage.

Swallows come to the news agency, pear flowers lag behind Qingming.

Yeedo has been continuously recognized as a national "high technology enterprise" on 2014, 2017 and 2020. Recently, it was officially awarded the "High Technology Enterprise Certificate"(GR202011004313, 3-year validity).

The recognition of a high technology enterprise is a comprehensive evaluation and recognition jointly made by Beijing Municipal Science and Technology Commission, Beijing Municipal Finance Bureau and Beijing Municipal Tax Service Bureau on the level of organization and management, research and development, transformation ability of scientific and technological achievements, core independent intellectual property rights, growth indicators and talent structure of the applicant. State Scientific and Technological Commission of The People's Republic of China will issue the Certificate of High Technology Enterprise upon approval.

Yieedo has been recognized three times in a row. The company will continue to uphold the corporate values of "scientific, integrity, collegiality and sharing", increasing investment in scientific research, cultivating compound technical personnel, enhancing the core competitiveness of the enterprise, and devoting to become a first-class medical products full life cycle technical service provider.